FDA Greenlights Second Pooled Sample COVID-19 Test As Crucial Tool To Reopen US Economy

US regulators have re-issued an EUA to LabCorp’s COVID-19 molecular diagnostic test for pooled sampling. While the method could speed up testing and use less resources, it also can result in false negatives.